See other companies on Welcome to the Jungle
Closed Loop Medicine
Single prescription drug plus digital therapy development platform
- 21-100 employees
- Healthcare
- B2B
- Manufacturing
- Biology
- MedTech
- London, UK
Jump to section
Company mission
To improve patients’ lives by creating closed loop models of care.
15% employee growth in 12 months
Our take
Closed Loop Medicine has created a proprietary platform for the creation of drug plus digital combination products, considered the next generation of patient centric pharmaceuticals.
Closed Loop Medicine has induced a shift in the industry by creating a new standard for the future of care for people with long-term conditions. Previously, precision medicine had only been possible for a few medical conditions, but Closed Loop’s delivery of behavioural therapy with drug therapy, as a single prescription, has changed this.
Funding raised will be invested primarily into its personalised drug plus digital therapy products. Moving forward, the platform will see further development as the company accelerates the registration and commercialisation of both the platform and its precision dosing products.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- 25 days holiday (plus 3 days Christmas shut down)
- Private Medical Insurance
- Life Assurance
- Hybrid working
Company values
- Integrated holistic health - Our products are designed to support patients, in doing so we aim to support the whole community of care around them.
- Experience and evidence - Our products are built to the highest medical standards on our unique platform that isn’t accessible in any other organisation
- Progressive healthcare enhancement - We seek to move healthcare forward for the benefit of all
- Multi-disciplinary collaboration - We bring together clinicians, engineer, designers, academics, regulators and patients to solve the biggest challenges in healthcare
- Safety and integrity - We value the importance of data safety and integrity in every product we develop and patient that we support
Funding (last 2 of 6 rounds)
Nov 2021
$16.6m
SERIES A
Jul 2020
$0.4m
GRANT
Total funding: $21.3m
This company has top investors
Leadership
Hakim Yadi ph.D. OBE
(CEO)Previously served as CEO for Northern Health Science Alliance, COO of Life Science Investment Organisation for UK Trade & Investment. Currently Non-Executive Chair for Health Innovation Research Alliance Northern Ireland.